|Articles|May 1, 2012
- Pharmaceutical Executive-05-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - May 2012
Marooned at the Top
Advertisement
Articles in this issue
about 14 years ago
Pharma 50 Comment: Seeding Beyond the Baseabout 14 years ago
Value-Based Pricing: Too High a Price for UK Pharma?about 14 years ago
Pharm Exec 50: Growth from the Bottom Upabout 14 years ago
Country Report: South Africaabout 14 years ago
Managing Information Overloadabout 14 years ago
Super-Size Me: Optimizing the Information Explosionabout 14 years ago
Government: Big Pharma's Best Friend in Emerging Markets?about 14 years ago
Information Overloadabout 14 years ago
Pharma's Winning Innovative TechnologyNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals
2
Pharma M&A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-PNPLA3
3
From Insight to Impact: Making Real-World Evidence Actionable in Urology
4
Pharmaceutical Executive Daily: Zentalis Doses First Patient with Azenosertib in Phase III Trial
5